EU Pharmacovigilance Obligations During Clinical Development
EU Pharmacovigilance Obligations During Clinical Development Pharmacovigilance Obligations During Clinical Development in the EU Ensuring patient safety is the cornerstone of clinical development in the European Union (EU). Pharmacovigilance obligations during clinical trials are governed primarily by the EU Clinical Trial Regulation (CTR) 536/2014, Good Clinical Practice (GCP) guidelines, and pharmacovigilance legislation aligned with EudraVigilance….
Read More “EU Pharmacovigilance Obligations During Clinical Development” »